Comparative Outcomes of Tirzepatide and Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes.

Journal of cardiac failure2026PMID: 40945773

View on PubMed DOI: 10.1016/j.cardfail.2025.07.026

Authors

Kishimori, Takefumi; Kato, Takao; Wada, Atsuyuki; Tani, Akira; Yamaji, Ryosuke; Koike, Jumpei; Iwasaki, Yoshihiro; Matsumoto, Takehiro; Yagi, Takafumi; Okada, Masaharu

Keywords

Heart failure with preserved ejection fractionsemaglutidetirzepatidetype 2 diabetes